Cas:161601-29-2 (1S,3S)-3-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid manufacturer & supplier

Chemical Name:(1S,3S)-3-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid

CAS.NO:161601-29-2

Synonyms:(1R,3R)-3-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)cyclopentanecarboxylic acid;Cyclopentanecarboxylic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-, (1R,3R)-

Molecular Formula:C₁₁H₁₉NO₄

Molecular Weight:229.273

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:382.5±31.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.495

PSA:75.63000

Exact Mass:229.131409

LogP:1.30

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (1R,3R)-3-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)cyclopentanecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclopentanecarboxylic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-, (1R,3R)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1R,3R)-3-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)cyclopentanecarboxylic acid Use and application,(1R,3R)-3-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)cyclopentanecarboxylic acid technical grade,usp/ep/jp grade.

Related News: The Environmental Working Group, a nonprofit advocacy organization, applauded the bill’s introduction. (1S,3S)-3-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid manufacturer The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. (1S,3S)-3-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid supplier Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs). (1S,3S)-3-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid vendor The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. (1S,3S)-3-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid factory APIs are generally manufactured through a variety of processes that include.